Gisele
Gisele Batista Veneroni, Sao Carlos BR
Patent application number | Description | Published |
---|---|---|
20130029328 | METHODS AND KITS FOR THE IDENTIFICATION OF ANIMALS HAVING A GREATER POTENTIAL FOR DESIRABLE CHARACTERISTICS, AND FOR THE EARLY IDENTIFICATION OF FAT DEPOSITS IN BOVINES - The present invention relates to a method and a kit for the identification of animals having greater potential for desirable characteristics of meat quality, rib eye area (REA), weaning weight and 18-month weight by means of the analysis of specific markers. | 01-31-2013 |
Gisele Clofent-Sanchez, Le Pian Medoc FR
Patent application number | Description | Published |
---|---|---|
20140328753 | Antibodies for Molecular Imaging of Vulnerable Plaques in Atherosclerosis - Antibodies for molecular imaging of vulnerable plaques in atherosclerosis Antibody specifically binding to atherosclerosis lesions for in vivo imaging and methods for in vivo imaging of atherosclerosis lesions in a patient. | 11-06-2014 |
Gisele Dos Santos Ribeiro, Jardim Sâo Paulo BR
Patent application number | Description | Published |
---|---|---|
20100070341 | METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS - The “METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS” is related, more specifically, to a method prominently developed so that the outsourcing clients, owners of networks managed by other companies, such as banks and other companies which utilize ATM terminals, are enabled to perform a follow-up and assessment of the behavior of their parks of ATM terminals by means of statistical analyses and/or the generation of graphics of updated indicators within the shortest period of time possible, thus providing conditions for the making of strategic and operational decisions based on information supplied on-line. | 03-18-2010 |
Gisele Dos Santos Ribeiro, Jardim Sâo Paulo BR
Patent application number | Description | Published |
---|---|---|
20100070341 | METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS - The “METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS” is related, more specifically, to a method prominently developed so that the outsourcing clients, owners of networks managed by other companies, such as banks and other companies which utilize ATM terminals, are enabled to perform a follow-up and assessment of the behavior of their parks of ATM terminals by means of statistical analyses and/or the generation of graphics of updated indicators within the shortest period of time possible, thus providing conditions for the making of strategic and operational decisions based on information supplied on-line. | 03-18-2010 |
Gisele Gellon, Saint-Martin D'Heres FR
Gisele Nishiguchi, Albany, CA US
Patent application number | Description | Published |
---|---|---|
20100056576 | Kinase inhibitors and methods of their use - New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one PIM kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer. | 03-04-2010 |
20100216839 | Pim kinase inhibitors and methods of their use - The present invention relates to new compounds of Formulas I and II, their tautomers, stereoisomers and polymorphs, and pharmaceutically acceptable salts, esters, metabolites or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the inhibition of Pim kinase activity and/or the prophylaxis or treatment of cancer. | 08-26-2010 |
20120134987 | KINASE INHIBITORS AND METHODS OF THEIR USE - New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one PIM kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer. | 05-31-2012 |
20120202851 | PIM KINASE INHIBITORS AND METHODS OF THEIR USE - The present invention relates to new compounds of Formulas I and II, their tautomers, stereoisomers and polymorphs, and pharmaceutically acceptable salts, esters, metabolites or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the inhibition of Pim kinase activity and/or the prophylaxis or treatment of cancer. | 08-09-2012 |
20120208815 | PIM KINASE INHIBITORS AND METHODS OF THEIR USE - New compounds, compositions and methods of inhibition of kinase activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one serine/threonine kinase or receptor tyrosine kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer. | 08-16-2012 |
20120225061 | TETRASUBSTITUTED CYCLOHEXYL COMPOUNDS AS KINASE INHIBITORS - The present invention provides a compound of formula (I): | 09-06-2012 |
20120225062 | NOVEL KINASE INHIBITORS - The present invention provides compounds of Formula I: | 09-06-2012 |
20130336965 | NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS - The present invention provides a compound of formula (A): | 12-19-2013 |
20140079693 | KINASE INHIBITORS AND METHODS OF THEIR USE - New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one PIM kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer. | 03-20-2014 |
20140275003 | BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS - The present invention provides compounds of Formula (I) | 09-18-2014 |
Gisele Picolo, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20090203618 | Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification - The present invention refers to analog compounds of peptides having the amino acid sequences SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4, including analgesic peptides derived from snakes of species such as | 08-13-2009 |
Gisele Walmag, Tilff BE
Patent application number | Description | Published |
---|---|---|
20090301338 | Projectile Made Of Steel Softened To The Core - The present invention relates to a process for manufacturing a projectile made of steel or based on iron, for a hunting or sports cartridge, for the purpose of giving it a Vickers hardness at room temperature of between 40 HV 10 and 110 HV 10, preferably between 40 HV 10 and 85 HV 10, characterized at least by the following successive steps:—liquid pig iron or steel is used, hereafter called liquid metal, the carbon content of which is between 0.8 and 4.0% C by weight, preferably between 0.8 and 2.0% C by weight;—the liquid metal is cast using a steam or water-vapour granulation process to obtain spheroidal steel particles;—said particles are subjected to a heat treatment for softening the solidified metal by graphitization, while remaining in the ferritic range; and—optionally, said particles are subjected to a surface coating treatment. | 12-10-2009 |
Gisele Zapata Sudo, Rio De Janeiro BR
Patent application number | Description | Published |
---|---|---|
20080275105 | Selective Muscle Relaxant and Pharmaceutical Compositions - This invention refers to substances able to cause selective muscle relaxation, pharmaceutical compositions containing such compounds and their use in the treatment of muscle tissue diseases, with such compounds complying with the general formula (I). | 11-06-2008 |
20100130575 | COMPOUND WITH ANESTHETICS ACTIVITY, METHODS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME - The present invention is related to a new series of chemical compounds, namely 3-benzyl-imidazolidine-2,4-dione substituted in the position 2 and/or 6 of benzyl ring by halogens as presented to the molecule named LPSF-PT-31, GIRSUPAN and its therapeutic use as drug with analgesic, sedative and adjuvant of anesthetics activities. The invention is also related to a process for production of said compounds as well as pharmaceutical compositions comprising them. | 05-27-2010 |